Pfizer oncology R&D exec heads to Aduro as new CMO; Army dumps Tonix research contract
→ A troubled Aduro has recruited a Pfizer cancer R&D exec to take the chief medical officer’s job. Dimitry S.A. Nuyten is moving from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
